US FDA Closes Out Problem Applications One Federal Register Notice At A Time

 
• By Ramsey Baghdadi

The refuse-to-approve decision for i02/Intarcia’s Type 2 diabetes combination product is the latest example of the FDA reaching final negative decisions on challenging regulatory cases.

Federal Register
Federal register notices marked the end of several long-term FDA administrative cases. • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards